NEWS
Clay Banks / UnsplashNOK 16 million to new RWE company
The Research Council of Norway recently awarded grants to several innovation projects in the industrial sector. One of the lucky companies was the newcomer NordicRWE.
The Future of Cancer Treatment
For six years we have hosted The Future of Cancer Treatment (Fremtidens kreftbehandling) with the same partners. What is this seminar series all about?
OUSBjørn Atle Bjørnbeth joins the board
Dr. Bjørn Atle Bjørnbeth joined the board of Oslo Cancer Cluster during the annual general meeting.
Nye kreftbehandlinger krever nye samarbeidsformer
Debattinnlegg: Innføring av nye legemidler for små pasientgrupper tar unødvendig lang tid. Noen blir ikke tatt i bruk i Norge i det hele tatt. Det er en utfordring, skriver artikkelforfatterne.
LINK MedicalLinking with the community
We want to highlight the fruitful collaborations in the cluster. In a new article series, we present members who have a cluster story to tell. This week, we meet LINK Medical.
NovartisNovartis enters IMPRESS
Novartis joins the IMPRESS oncology study with six of its cancer medicines to treat up to one hundred patients.
New partners join precision medicine consortium
Five new partners have joined CONNECT.
Meet our new competence broker
Eva S. Dugstad is our new research and industry facilitator aka competence broker for Oslo-based companies.
Turning offices into laboratories
Office spaces have transformed into laboratories in Oslo Cancer Cluster Incubator.
